Literature DB >> 17846917

Neurodegeneration and chronic renal failure in methylmalonic aciduria--a pathophysiological approach.

M A Morath1, J G Okun, I B Müller, S W Sauer, F Hörster, G F Hoffmann, S Kölker.   

Abstract

In the last decades the survival of patients with methylmalonic aciduria has been improved. However, the overall outcome of affected patients remains disappointing. The disease course is often complicated by acute life-threatening metabolic crises, which can result in multiple organ failure or even death, resembling primary defects of mitochondrial energy metabolism. Biochemical abnormalities during metabolic derangement, such as metabolic acidosis, ketonaemia/ketonuria, lactic acidosis, hypoglycaemia and hyperammonaemia, suggest mitochondrial dysfunction. In addition, long-term complications such as chronic renal failure and neurological disease are frequently found. Neuropathophysiological studies have focused on various effects caused by accumulation of putatively toxic organic acids, the so-called 'toxic metabolite' hypothesis. In previous studies, methylmalonate (MMA) has been considered as the major neurotoxin in methylmalonic aciduria, whereas more recent studies have highlighted a synergistic inhibition of mitochondrial energy metabolism (pyruvate dehydrogenase complex, tricarboxylic acid cycle, respiratory chain, mitochondrial salvage pathway of deoxyribonucleoside triphosphate (dNTP)) induced by propionyl-CoA, 2-methylcitrate and MMA as the key pathomechanism of inherited disorders of propionate metabolism. Intracerebral accumulation of toxic metabolites ('trapping' hypothesis') is considered a biochemical risk factor for neurodegeneration. Secondary effects of mitochondrial dysfunction, such as oxidative stress and impaired mtDNA homeostasis, contribute to pathogenesis of these disorders. The underlying pathomechanisms of chronic renal insufficiency in methylmalonic acidurias are not yet understood. We hypothesize that renal and cerebral pathomechanisms share some similarities, such as an involvement of dicarboxylic acid transport. This review aims to give a comprehensive overview on recent pathomechanistic concepts for methylmalonic acidurias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846917     DOI: 10.1007/s10545-007-0571-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  65 in total

1.  Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function.

Authors:  I Pela; S Gasperini; E Pasquini; M A Donati
Journal:  Clin Nephrol       Date:  2006-07       Impact factor: 0.975

Review 2.  Approaches to the treatment of mitochondrial diseases.

Authors:  Salvatore DiMauro; Michio Hirano; Eric A Schon
Journal:  Muscle Nerve       Date:  2006-09       Impact factor: 3.217

3.  Acute extrapyramidal syndrome in methylmalonic acidemia: "metabolic stroke" involving the globus pallidus.

Authors:  R Heidenreich; M Natowicz; B E Hainline; P Berman; R I Kelley; R E Hillman; G T Berry
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

4.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Authors:  W Lehnert; W Sperl; T Suormala; E R Baumgartner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

6.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.

Authors:  Hiroko P Indo; Mercy Davidson; Hsiu-Chuan Yen; Shigeaki Suenaga; Kazuo Tomita; Takeshi Nishii; Masahiro Higuchi; Yasutoshi Koga; Toshihiko Ozawa; Hideyuki J Majima
Journal:  Mitochondrion       Date:  2006-12-13       Impact factor: 4.160

7.  Type 4 renal tubular acidosis (subtype 2) in a patient with methylmalonic acidaemia.

Authors:  T Ohura; M Kikuchi; D Abukawa; H Hanamizu; J Aikawa; K Narisawa; K Tada; H Yunoki
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

8.  Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment.

Authors:  I P Hargreaves; Y Sheena; J M Land; S J R Heales
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

9.  The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria. A possible explantation for hypoglycemia in methylmalonic aciduria.

Authors:  M L Halperin; C M Schiller; I B Fritz
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Cardiomyopathy in propionic acidaemia.

Authors:  A F Massoud; J V Leonard
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

View more
  41 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Delayed enhancement cardiac magnetic resonance imaging in propionic acidemia.

Authors:  Satoru Iwashima; Takamichi Ishikawa; Takehiko Ohzeki; Yusaku Endou
Journal:  Pediatr Cardiol       Date:  2010-05-19       Impact factor: 1.655

3.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

4.  Renal transplantation in a boy with methylmalonic acidaemia.

Authors:  Joanna Clare Clothier; Anupam Chakrapani; Mary-Anne Preece; Patrick McKiernan; Rajat Gupta; Anita Macdonald; Sally-Anne Hulton
Journal:  J Inherit Metab Dis       Date:  2011-03-17       Impact factor: 4.982

Review 5.  Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation.

Authors:  Stefan Kölker; Peter Burgard; Sven W Sauer; Jürgen G Okun
Journal:  J Inherit Metab Dis       Date:  2013-03-20       Impact factor: 4.982

Review 6.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

7.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

8.  Peritoneal dialysis for chronic renal failure in a patient with methylmalonic acidaemia.

Authors:  Bemigho Etuwewe; Caroline A Jones; Shipra Mathur; Katherine P Wright; Andrew A M Morris
Journal:  Pediatr Nephrol       Date:  2008-12-02       Impact factor: 3.714

9.  Multiple OXPHOS deficiency in the liver of a patient with CblA methylmalonic aciduria sensitive to vitamin B(12).

Authors:  V Valayannopoulos; L Hubert; J F Benoist; S Romano; J B Arnoux; D Chrétien; J Kaplan; F Fakhouri; D Rabier; A Rötig; A S Lebre; A Munnich; Y de Keyzer; P de Lonlay
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

10.  Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure.

Authors:  André C Affonso; Daniele G Machado; Fernanda Malgarin; Daiane B Fraga; Fernando Ghedim; Alexandra Zugno; Emílio L Streck; Patrícia F Schuck; Gustavo C Ferreira
Journal:  Metab Brain Dis       Date:  2013-03-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.